Compare IPSC & AHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IPSC | AHRT |
|---|---|---|
| Founded | 2019 | 1979 |
| Country | United States | United States |
| Employees | 78 | 98 |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.6M | 501.3M |
| IPO Year | 2021 | 2013 |
| Metric | IPSC | AHRT |
|---|---|---|
| Price | $2.27 | $6.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $4.25 | ★ $7.00 |
| AVG Volume (30 Days) | 644.7K | ★ 786.2K |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 9.30% |
| EPS Growth | ★ 91.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | $854.92 |
| Revenue Next Year | N/A | $11.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $5.13 |
| 52 Week High | $2.97 | $6.95 |
| Indicator | IPSC | AHRT |
|---|---|---|
| Relative Strength Index (RSI) | 49.15 | 73.69 |
| Support Level | $2.15 | $5.93 |
| Resistance Level | $2.41 | N/A |
| Average True Range (ATR) | 0.13 | 0.18 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 56.67 | 95.15 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
AH Realty Trust Inc is a real estate investment trust (REIT). It owns, operates, and acquires high-quality properties across the Mid-Atlantic and Southeast, creating lasting value for investors, partners, clients, tenants, and communities. The group focuses on operating and acquiring high-quality, well-positioned assets with growth potential and delivering long-term value for shareholders. Its portfolio includes Harbor Point, Southern Post, The Interlock, and Others.